y_80?mBLʴtbڧ@vIl'6ے@y!H::::뛷|ot(=YA(}N$ĝLauY$3/( d$e?uu9fG7G< fa·t'N*7nS?X>e2E+?AW \}7]ħ/c5&nHgnPcbDn,uiv787MЛ{WaAWzh|1묛_5ۼ,7C;]Y~ਫ਼uz-hl㤛}= I4 -ڍn֙Im{b|xzՋyy ӻW!x+m?~HWj䨧Y?׺PMvl{_z39"sW7if mh"iߣݰu~ލga4it fio0m| a_ot˶Z؄U7gz/O#L7*<<U,Ӳ_i{;18n>N[qp{^8# <'LC;i @5^w5Cq3XӅQ,`'Oa޳MURUE ᦖzZT)zz3<@ʀ+uQkU1D'8_g:OWmFOUbpXtwN6 xND "i-ﻳjF>] _+v/Cd얃)~/o[F6NԃD_$sq 4T/{ćspz,HAk`[)Xgs|=kV=9b4-OuМ'Y *?'5'?}\M~^~>^^էWP`ӣoGm^4<^OѧOWw^}j|>|?|8=l4@鳛_߿:Fف"d_V#0 /F#ԋ!R`uMF׽tc.9^Lp+X&3n `d{^ݾ4y޼hܾnqCOX_TWfϧ>_gW/ێk¹ۿ{qfΐ8Kܻ]ptLvDd=%hL7 Z9إx ]xcRQ<~ U7j8"KUy Qhwz9u,O[f0eyNz>@1Q/q鍝Ah#/O[xo >́BGs h>aw7RUp|3r ):h^޾rWcuj0d7K^`г=q7w—Ij5vzz?DDyp;T*^|Po>×.n0Ӌdp}mw>\ ^n@&&$pdC9Jvv:JkJN^oZSi1lޟ緯F})-h5gˣ*< [nޟۣgCut,ޢl7@gHTq}q1r_l/Z5_*Ŵl[w[%$قilsQgaYz}U|ܟtEa݄-6SRGԿ>[2Vy3w8T;Ço㛳侉bwspc\|!wԆSu]l7"=?O[`.d>6>}ξ_[׃eOB t<\܁!>?L hݱ3CrL[#Oun8y@oO%@!mM%@;C˻![)-؍5 5h?mmo/a jӰ'H?S?bƛOdvZ "`{|ZSx߾ܢ! |B]S|{5$hy^ma+OGx ]Cp\cy)3(uAD]LZWU )m"= G3?̈is(]890-Ru'E)wj [^)g+DUN!D";Z}uVBVQ%O#XSHGd ,J+c&U<`J)d rBIA0:ZZE<%[1׾1)6~l7Ҥun1rZ^.-v e.3F1,HhzpTο}Ro!B!#@,wp)+[/wMGs]mփޠ"{ϿAvh]zsB6ltAlN_[GLJޛz1G${>oݲ&jESyM,GŁ7ݿQ{p`r¥zAUї7^LQ} M/Öu`E> d~hb`⟥M ѿ ߫աG(Wr>S͏N|Kwo~OW~G yܛ^kIz\Wgei" 0Φy8Pxe!ӿ >r/O%S"ʑkI}0$8U{ί~#y_7H464_o/lUa.Bxhr ,#.`s2"@ ;dpo"tDB̍e[;| og?rF?~p:/"POFq'do_!,Ӌo0f2Hh8dmƓ.b/?_.>&J/#׫!ݥ~+$ #;=dVDQ:wj!XsC|zU^{+}A;L4<&X rnGx ԽQ\m DB(Gp)2B'D` +`Eh2S5@ $ʗBڼ]f`ТcK;t{;@ůؙ<2HZ,1(X~߾ղataP=p_dJ "(waAW5UDJmDKH3 !S(tNnDeKԺts|.Tp޼kK] fzR26AZoTۥ+(P]g!Vh8,T&2H41-;䓫@uJ"(4Y"׋LEVI<+^H˳}}M}:OrQk.e_m1yȋQ0+Zֳ~#PQb_>Wfw;8Z \>L׌cߑvCOA0.MkNwvwp^din`cn3~{@A<<~3/>h";ez;q0dewKVbyЉt1Y4n5.Dۂw1yp^Xm&$~1%#Ge}{;1 >~lL~U bPvTv8q1nƗ1\|K?]]4/goo^qpl?~ǩ{{wݾ}5?xws_}qm0lWۋ yS~sKkS~1/A<9]n_-^Gj_fo/OͷzyvpJMj?&TS=oo_OE Q7bc^<]H?$?o_p\wvm\K5c.I־?2MFw6< }S η׬ݔ.G`?n5>* .M!pؙ^\tnmվm>/6Ҍ>AqTß~9Ylmkᓷo϶7ߖcWϷۇwmlH٧oڬםۑ_zpexN^Ƣqӻw4<~+ F|n>pZ=}y,q}:X^_oη{ip51@tWF|?_2:mޚ{\w||NF|x{7:@䫱_;}?|i>{u|u4ikAGpuy>FtPS_ﷇ?a}g>׼4foFPSeOS?u|x9yuzc}o_mL_<4 ; ozp|ܞl@X_HwyH!=<{QI?ڵ''3~}xvspl;ip׌tW6}k{K|{C\V? ?޾LhponϽ7}!xxp4m^nxr?u^_<_~y}go}l]~noO'߾w1^|~ټ1_߽tϫw7_/QHg?O#BWaL>}v.no?4߿ťw]|pxL_'G|t~239_wY7NRhEyp28h=k|wο؋{ʗ_}u0 OwשQWft^uCӧoo3ř?ߏmt9{Nwξ]: N/7adv+I&<:o\%>ޝݷƇo-A̩i:_| $|}i{_^z}]:TpԇC'so{؎ߙO=ܽ w߃_k\_pniK8͋ӷG/ywq޼zVut޿͎ճwҷ />4GOQ:7^}[BK^4ۻZ|~;R_;/'Io$>ۜ}|z ՗އ%uQ27kO +/>|3^iTJdzAc[w0H>W׃ Qw~0epuvxx~|4ۛw};pZ ˯óai%R)x}R%`E^5lh7?Ķ d/ :`A:W/'=LLg7NdL8)VGn]",얚wfhUvas]_}.y%'}UN5> e^Us0b yPbJ-ׯo/ ڞ}{,ooorT1%y`\hJ`4jx'e5ɯ^$;x&t Xڶp/q8bd3]4yK壜3S]4Dd9]9̜V`8L "wR< .7gJMl}rl?޶\KXowAN.pK&< *o9y;M/,\`ULZ*UB"ޔg}YH\el2G Ɉ53 [7+Px)ࣰ>Ws׋,3Xl&\:ſn{pq&'܈_Q]}b{ >EzZi+??TM*eNSlswAޱ+طw& Lr8P\3ߊȧt2KwQ|y7 {z?~ޛw%g::h@gw)t^=&[~_Ƥ0N~Gһڥ͆H*œ I)tWf{:$X%2+,{A7p{`+/jVm0I&AP8_u?QWIK"KX_zphp{!iSi/66W747}/qCչss$P뵤UsFwUt|RoNN$vojޏDBQGAX1:MMJV1gԠzV, =W?M;j83cT}g5{{%Ff zۉeo٪ zaw(<ɢיOMEm9eò&ivo1)̻ZG2_[5_QKOf0N"Mh(VW^搪 I BwPg'Un4$iII{ 4h5qyN& S/f+Xi#|;eޘ1T{Z gѴ;ȏ^XshG܍aw &C괾{EF]?J#;ƺS68G;n.]QHmdkgY:|o"_^4f*jz4 peo~KoR߿;.|WZ hIҫׯ5 ޝg=vӀQ͝W4qfic {rka*tR-Iu,l-K9evMY{/PuM@yQhT[3y1V}c`iC/ci0H;Ad8zV6 mV@\g#+|R,D,J=+P{o9Dy0)`h J>N ͣ`IvXK&'(e4U۶L4,\?뙾uFZ-,cXM%Ղͼ ˠN{ןf0wC;3S?\ e "ˤ4D>_.@;c8M](H<݄e:eۃ!Ī/8nҚK~sXF(Z~_,kckM«OWwATSƉ $^ڦ$'1n*N6["&ݬOBG.9-:%r횛Buu1ݕ:Жrϭ7 kXLfV6މڮ ^w͞;bX`bހ4 F?eQOrjM95֒3z6]rUXYE2cyK+{̍h؞3>@ף~>,MIV2X9K&v*!{ zͳd[߬gFb#+ e mljL`]@e$؍ߧ_;?|BIqʪ`5w |ɔXW1Ĭz5˫ !v-,dkXc%@q6]̽\o8 7@ '`k/;*u R%/[m$n&ĿC~ݤFWu84PFuT Sʄw?өO2̼6$?='?S^żIW` COP*/IA(G\!Zx(hj!;`M gekaMtd [I Uȟ`q~Ӌ?iTu DE\$r`rkѺTSж\mhDY`)+!¾;/ٺۛm#7lM{U+pp0v68mI2M]#P0ó"`^a&]=pRhj¿KEG;fr ѭ6'h?^S5Wvo`,azBiZzab>!Zw,";ail>u 1T(V "QCPyw!,xاγUiP`7^#nU`vaydK1W!g3""Gs3%|D!&° {dt"R$2?Hg"UhKWQȒ  +kUD)"ĬT P rUWIh=Au o0f"w ȍ0XSZE+*8رrVc9b6UX0X.܍U1t+'Q=0yBCm)R¹Y !Qiy˅sϝ A)sJB0n;0RQTN 0nFeYoleSآ(2oꝺ*jUeO(vVa ,"5ta8^_ \pRY4&z/ YF+d \ l~UA`o DZu]-Hߵrjv& 񴓢ЁQH,bo CD{"*C⧜NaW)N;[+jUK]32W);JMMAk,%W( IS~\!}h6Wn.axpXyܥ*2stt0X`f ayq3Kw*:cGN德JtyQp A8lt ke*X x;3^Nݣ؍c+RPMxm j♱4%-\F-nNԱrjO.*&ln2!PnߝFÁtfgޠ~='zDAF;4ǹTNMM"HEN '.Z'i `x&*=n6e8ȁMR ,-8l=u?pׅn؂4[+c9D&Ghj:6qF])/a쫇WXT K]8]̜`k 0Ǜ3ò63vp& QVeZ0 p"ڵM,R.tu.6y섮д R] 7ҹogx~vj4r5懗AܙRviu\aQ%Nk( Lƻ5_[ơ=G'T1yB.?'AuI3gcm|j˩NL%#U4*5)oSZNuJ+\/p GOVc, }z oI\dMGj:K@-.bhNt#m:kl5Ks2[.N/ljfLQ4ռK.4 r"nՑyV(Q3b.Z ׁ\(3Xӧf!zBQg)RL67.2v7"1ji`uzq{8~x#-xf2j㷲?#\1?dyj ,7׃F<0܌l^#, -@43E 0] }UxMm&Rs؈'?Xۼ+Xm{p r7wxE^-̷jw=enbtMМC4ᖉn(jt:|͉<{z!jfy'ꆃ -uo{'(S~e+* -Yvys{(fkc4f/eg 3ڵ*h-%?/;7\(HOSgN WPzI("n6 tRUߵh0;ݾmcS;?.UPL) 1uu'TFUj!5^onu9ݮK9ϖxE-Sč „{ M-rk D,7==  uQB_ϝBD` Sx^ט}|މv; (pWK<\X<$,e]jZVo6&`ywd^yd7bz-MZT#JQʁUvO}P`GYgMz.P-㞙jY긾*4'ذ;0Fnͷ_84QGz6F7P&]=oƮh4̣}yBU+WfU#,{Coڛ~W-o ]g⡐KƖFGsun0L ޮt*7'u%|+!oagjDR!ȳS3*iFU +o[qATgHEM+N (Cr*](Nf51O OSY)F{?  y^$^{Ya6_FH_ n}K3 +Q,U,;C–JKo%yL$|p}#4}0LVX )&YGeGIch2D \8" ZҊ ,5@%)7W-{E>h n`ě&ҲzhtVXlCjݙ5 M69muvģ/¼%0C*KocOF^VCOez"D$1?;`6v6ęfޝXzS7ڵ\׍돬Qv”8Rt&\DH`H ?ͩ8]A:sG &QK}O6TRrKµbaLh/$U=IRZU ΢TI"vh%`R&wʑ BjGbGk]aIIJJuIB47ȼ*|sy$Up^dN UE&賅K{Gb4‘w5`- -: yB+Z`Pfol3O MGfI!6#dqzWGx?t]uxn92ף!!$3IJ1? ㈓|FHYCQO&Ap(c?fؐ h?&!%2JFE47a b曟iW^CS -~釹 s; T&9wn6Mo&)ȴ67gz\NԵBdFl`>ll :vr #u *$}xqGd#uA8dA-bH+î,:4BOGN!ORh7u? >}N04v0:.1t:#G/D$6gSoF )1_9nԡw0mA!+8ƦaUu.[h8+&v\NA|urK2J+K)zd4[2oTtCa/(@x~g/@mnHV C7&k4qM1 ۝.{6v`؟ᴀ{Ù6Qr T!3³ʵ$`O #R3*OPe1p͖B[- :|-wHbiR$=N@̓LH[.\^Qمۭ^p{,FVWM!%TgJ׻Yv|q|TUz!z `Ub8N@D!a bGQ&A=bHiP&]GX=hpnFԫ[QT ᗩz񕮥fj'~*,f>_39JEK^U@A^6߳'*&n'AaN{D[ bGei,ҔUog_ hH >N++Ƃ_㪫Jeܙ)r433dЍO*)iAOIA2QNqWf M_Iݑ@}Hd) \6HLOiIxi L7$G:`imVpƃsƋ-q*4=A Tl24~< +8lTߪ=$prz9'au4mF:sC6Ul3V}H${khVk(CMNܬys4(+jK  QBSs; ķroѠ7Ri7+jnԩ(hNo@8тRB74{$RP]HYyO`l@vlHFǘ g`,%JsR&, +{%Tf jDPRϥ%DvMT,o Ng@A< -qP?dfd.!囝+T'Tfp˥6|W\Ffro)ӆSB97*;fiBsr-p], RBRPȠUoP!8m" 0U,] oί7C C)rN3v5HuJS׻AE>xJuE) +=Y!CXJƹBd]@ &i VQQ 0KM3J<3 )[OD/ J?7W8e􈊆xQE̍+,=:u] :˩Ab-(|ebaGeё%GZ7aDpϒ{ ʘM.D5D27LoLF"<ԋ̤Y8s־b$?ߦ ](UFn$#W'42|e h4P"wŃOUT~a>*1ExxaCk39jUedETSj8/$"o=5AU+V|RJL-F _dPz^\--hn$|" L%'Ъz@R&W{/_Hغ wf<ޢ`„Ap̓w{۫ bio]694§/XBVEpId0:VsgG|S6$t(;U GwI tNTKoh,A1i|̵[aS/-ӄG)4bWD$͑B'n=kË9 /!܉[y/ Z.-W1&:b@/rqZ|\pGȚ鞀lܡp>| L\M-9K.-Ex7]W˱v070؛(dmjܕVFG1ej6Gulo( {TIb^ sMSF 59\st[+1{)َ'[el׀3tz:Bea!$ #d t|}*Bǀ%9"{{57ڸQtRY3tۻ; " v9WJXHGs[p~X2nBv=뵸IT?'DZ+Key,T(L۶c O [pP} U,D*b첥e# Q9bu"1TJxYĈQYD-hbq;1Yԋ\fr,RzsIOI/#"Z4t,u5b:Kg+1ʉsg64cbREAyRb@ϮM- kiGdy;(2-.3 )MVmɵybD GfKxS5|pbeƏ$¸q.4 |a*_/Khw_]WLNRRPQZ3-kI]>%?잔[T{~DY]JK%l--Ko-;ipAGNdz;CYدjÒ'nط'"kSYd#] S7wn /]?nЗH ^i,_ѐh[_ZEFNtG]0RԡUYFacnArO Q,,a\s5Ur7Q^2tY̜M=U:*( < %z:Q %N kcs=y{a3*'6A{!,E4yo6`މa {{cWo%̝XN5Kuv'EfYs(p:Qެm1M*._vebztbIط˕ ( i>#_?]aTyQDHd?p0G3\M#f4a8s(]d`Zn+v3E2q@]))t`"w "aߥz +N^D/DL6J)J۳OId8sƙ5hp:feRuc$Yg% B,7Iu.' m`_hcpS;icEHÃS.:vXGr>ˌMGF0k``]c5`򝾞x6 kܕ={DGXkf訴Vvę &,*vmi8]q!{]u :Y;Wþ3A AXGob&go{{{TJ0qTpZ5FM`ԈȈwcϭ(`ZƅmIAMCwW|3h݄wJm.{T@XlU S&)p6iա" |(4wG)?+cXacR/Zu 81C]G.q͏aEč_~ݶb Z-?Ł871%%߿) r@𕃡͐jֆ`EzWǯ6[diG>^PHTF>LUYU.ɢkd5!qr^xiV6i38X4x-R;7"`Ul#CV}Miҧ1 ;raOBORL2r4(MñAK!uJJ|1AleeQ"vh*yLCp(B9Fl\GfI+ Im1_gY;4(/dpJWf# k`U/u/)?YU ojCugX2HX56' _(4ݡ[bl wsZ/8ƴ;)GN䀟mlL5ʅYבؠ,AD'0qzQ(SYZ0Q_Zn_?代f±٢X^jhAYk D cKeCs>]*j}ǖ᯽X$<)ГułzP{?wk6 /øRO[7UY8J]9KK6O_њՂzqt., P±k y>+g؄ڸq ĤzV;DZ@ġgj&Nu-8`|zy^dQ&!?/A89諁cV/>Pтm:lÂehݏ|uRg{{Ro˙g_y$q]!zQmPR FmaMV+,"(9F\^xܐ w>y+efҟ#gj(XBuU-=R5<TsS*:5#JV5np6Bwkz)Y V&< Е SnSN-}扻E+ Z⮟mi^-l0$_. lʸLBKI,"8'C`r{!Ig9ӔQ,憶I,{M`rTh86h}7>EM]Y[ǚ8٨%!NN!cU9"#-۲s3n8@nz9e1У(Yo6u s-{0 ^rTa@9,֪s6fi"6&_a'tHtPt2!_y92 ӑ[B-FUhԴ‰1U s0ND"W A, ȁiSwi֙\*\q".G#Tf۵Nƙgq (M,̔rj/ U7[0`ot</3qF|yXѨd&ӡ0מ2޹T2FMǶz:-Pt 6`1簕/NYB@± s`aOe^M(|2{(3<<bܠyF}OPNFJktg[C7sKT&쮞x= W nn-oCe@+]!;¡7p&ahMIFT9єLeMx CI(m { \ˣ4SdX8NY&GxXÞcIh5vd`4Tz~Zp˱; 3l`^q+2˪Tܗ+,<p1P3OĿDN$"j`x~'1g3&ݝq r! ׭gRwb1k3B4!h>9I7eg>toƽ&WG-NJ\係^&Y"98]A.砂P*c`jd&3FIf *h5l^ .>y&Ѥj~ 32CpNFCM@f3] H s5*Sa"TAZyOy}( eе8:5reh`o-j%~9yǗX`{*K Kw,*Kk@e<溨h|Y@XjJ?-}G$T%FύDŽ Y!QN??׀'ځ^n09w'*2r-'f&(ݓ#S۵^2֧,]ΕAiGq8wDqo$ӹ!GQqhdFm[9yO Tbiגq#6\9)l<v,sЃSlv*jVIRJa^b ZEz0 _AIKMnIݺQ/HrU֏Dz(n4{,&[M\WF6w5 u +G5n kxrDQ*ڦe\)irB$ LXz'Bs%!5Kt[`폰 kIxQwl\j`uW(>ODVb_K̵{tWܠ%iԱ껳i\3OJ,}no&:`eF(ȟ PwQn3vIJz BG:vf'#s QJ3O߱Lj eF!xRxU+|afTЧrXc pyk"VݠkCAQ*S@)LUȃz; v՛vy͇xLMGr 8h'WmcQr]Yv?ֲ(zOkz;Fv|yaY;~4>'ГȖ~2!"$ ((2g ](nNSc.fJ 4V:I7w4=}DzmϷSqX՛#@#{BOhm䁊a &Pmh@CGv-:NuZTgix”<4OX]M U.80t!Vn&]5NL/xz*jqx-~m"$Ez,/_I'nDJ8ؓxBͩىNtXu-=?sr8si.};zAZ4uQα3'*[z<⺯y%Nj#JqqԵBTIWu2 >}r@n^;A|w%* =G4j|0ŝCQaZ%k]zļ79Myt_2XfI-=6سYu/ce3r1v^XÅ{JT<499tp]"Y 2v?_*t`zm(e^7OK<\#OEt@{eD8% !A3싍X]$s=&&#x؆Zr/%,ԋvcs#ĹJ2x%@kRQHA*CDML-;q<ňN!n%񷮍hVOuM06TLHo1<`zu L&0cŪTyNy_!W(qv;o䶀:#ui2mv;ei`O|ltCc\i"#$B\ݵgXh$J⮉3ro! cNBJk¿Kl2Śiobdu|ӒjT]}_ lZ.*4A !<ңp^?ќMB:b:Et(E~-<<2`>G÷իibΝVM%Ǡ1Ǜ(p:׼I/n#4ogImSNMJIff50ed}lakDC$ @~T6XtgJ^-* ődwF8ßqH(F.~wY#^[lG:Bh9F SVMc>6zQxK -n:95&w"0qqqL_*Ld}yj0＊ Qî]iRg2\nƭ͉p]wM5Q䆴c"Sp緺ZHY~LU˪ǔ$\xf]qbHtt ;&gyH14 ulW?i#2Ƥ_OBE"TlL&KT:\Ѭrqצ$?5[wZ%w7YZ$˹\ӮI H&]=a!q}UK*'wu0AOd.%F3)U=<.4AJNJ_;VI7pvJ3rYEky35AD 6 <{w6$200]˲0z_f\@Z+K7Q;Ù5B~xeidn|l6F2Rщ-d9j'fg3Y,'[~^nе'-^NnǁNbyJgzPZm7FHK@k@$Dʥ]k4yU"hhd5AXV)sn x9FQyXJJ\|L*ZVz~XMӊR:$%sy v1[1+D4wt(KʏЧ`pG(~@~w??6h઱frrk*-op~R %oG܃6g'>2B,s&hZž_)twXi8]fmYo[Sݣ`4JWJfY9ݤ~| f%ݭi˅ꆻ͡Լ|-(k^mre0]*OgGcS~9@zdZԛ3}Z.'\ké2}ul"ׇiFk+]KbNF4OqB,{'K+f X*daF[HY*<`s*` B]^؋ u}R>6cO< 0wzqSc s|bΖ3IôcXø'zH{ajESG5 QחL,7`L;c_a6aHp0{ .c`uZ{@OI'³Rǡ `-Civkyt7L] c`hrr=R{u4Jb_ڴמm؊kFoz״ ]@K*fux$@S+0`~1~Βֽ!2QYV* [hO"Z1Vy`WCMޕyUrpŁuƴ2/y "Zb%;ԝLQH_/K:A樌^fc]:j"L>O|jQZ.m+7Ы `$eUz:įO&E3:Q*MhT`۶'d<憙lQ]k9qc1t*Q(Ў]/\bꉦ3VsZ|m1Hm8_8.Y>XMy .կY٦nUDHXϡNs &>,-K-IvE噧qJ:嵸~qdWԒ`9bb'YLdUƊ\D7ȹ*HgƎml|񳦊vڎx S ܁M PڽJ<Ͼ )4]"G_¾Ld&jvNiq{̝Dka6BD,<%dCV_E FJ8 hH<=,1 Ex^g"эj=68R#4 涥-~INGpdm:,h?ė#C@n$)8X`l[-ADBэBG(@M׊pzgV5֥U"ͳvֽu)Jnj8*M<$8 3 -7<.Дu3JrӐ_X{z& ťN0,is uQXvDP*0ddq #?ڧĞPRCAeN v TV_dwĎ TG<5`%=5=n(zȯx];h xrʺf8UX׳pV ׎ל:@p`tRS?a¶籗mxeUFR/wpG1 ]m G4dԵKmn{2KN$̵ZdZjpP m"ljnG)WYƹDmtℹ4F+0_WF}~pc4WGÙFEjԡi) N~(wґ\L[$02 ЍW- 28&9.ڒZe[$+v*|ܪc-p,?td,f>gQ6&.j82I~Pr~m|OJ+N5D%c&n{T &LB@9^U~+2?T(/!C{EBa>WA#m(j2 ~7ML<&/- ֦슠/=knFWxRMN@t.sfӴӏ,}d$(` 2sgEI}1 c.1qDF}6Hd\qO#(HQ:,g2H<P^7v፪]LIAԤʣ`[U2R=b[˜|}(u}Oi7qRF#={khz=`!*RR,N٢*)t+lr,cB;AodFyj]}}3Mh> ֠tz E6 OV'T{BVUĐ% pIj &:0h׆QIiO 5N3eZRbAC}uWS " u:& WiwqP# ŝRiL˄2OJLFVv%Ϊ'&eE*[6_gYl >aIaP8V 8z-^̂ꅒRܐNaR:m\du%G魆$fr7 &C4E YM4]::Σ6W,ghZFh"C ^Ze9 v_ݔZU;ł?@i7En^x?alJ>JF>ƌLZ.Qt<7uSZt1r=XvS6=m`dv l|ŇGȇ/_'!2nMmRps:w"x:(G;GD7 -8iGjpBciqrC/S # z+Y]=9aV<ދ_n8u @: S ngVw y#-vegAlTxJlc)O|\D #g;CuSj>N`fvG0s t² Xen sXB9Q;zYdl;MהSf9RpL'\M=qJCje]s;bXˈg-n=y.J+:;j gi-˅#@%Y=:MbP_O ͢+:-(]ӂZ5{:̅̆ *l*RU!Ȕm /s͗Yn*g[6r-2%Zx!-x/۲#2m ʈ2q2~'Cse)I% 5Se{1Fé:Ҝu'L`ue9gl=ȆSFIC皑* mX)TW`hSl>/'`Ji7k%}ݑd{^f.H9*. q?YP >64,\?뙾uFZ)JRꎣ46EXGs-2_VIE ʲ8aqHd4s?\;!V/J{J4OÙެ<;5N3f$ˁ33h aj \-@Jzǁ% zkI˵) ͌\lHE36,팘"N!,WlxbݍxZːBv 5E8D6 c5:ݾtWE]iipm1SwTru™Ne ' A>\&{J[ۥJ} .Zۯ#C*<hUSs[(2}(SG?FIIX"i&Л jqwuVra[dX0O sUp$gv )s6QP"4=l?"zkkt):)(8.컛uu^ s@3cq~ <_V وf(@"AwH/h#.!0*UNP7a8=G+,Y-,:bnFzPXE 'fS 6+d%$8j+lj%'xOMU-mijHNV(eϋ?ps16Aޜ8"kˎi~iO$^;-tuUXjE8P`c4K#QA)Δ$UWf!Sf,Y-P%tda#M@8 soWGM``.=b)s s0T&^ \#+W@?1=gfxSukOD`!CB=%1ͻVq -=qQ>\ U& S9`\t@Vr~*4.tFXF~ţDΘhX_Vv?ƬXս+.1  =rǬm\ fh4U; BzلI"M\U;ܣ<V" .ηL3JNv͖ G. ܔd_Ytb}F+;2kz%_di0pZ~0Rx #$B6p"#1Ǫ$VEXq 0q*.&rN )?~~b4"hOWMG̹P:|B*rHFHuqݛr&jF" -%{> U$o nԍ%JY Gr2Շ͗dR5 }lm}&iL7X4K`rC>'R ,b6_j,84]Sf3Ls'D!4ylGxgf0{x5 "=UVoI1($*EgïQu&%<L[9:TI&ѼJќ-G+xA >-=TߥEq 𪇘"*!n6u\ NFqHBL0(jjM)VS tuL YzSuTF|! x4kp;fA@ }{Z6Z.u0LlO 4}ب'īN矋~t^Dϟwy{?:xDe?p+dmj2@-ٸW" Q:$ԟL؆t eNF)8)@Fn ]ɂwi/<x 4Nt3Ss"2`{Lzh#k:5 _k_qv1%w1EtIgdOfފc $]^^xnz g{5`L9 JgA`&|bz~S}e~6`^^B4}pCt7 1/DRl iVgߕ3@\ |#oP+"o)\|9{$^@jY/ج*э8N[wQyd;0)`S${`WtOq➒7oĨ52JYۦ޵XqT6. UAΤ638f1~YFnSQ;yL*Vqtޙ )v`ðT_~_yQaC4Ѕ7<)+: &eF"z.ēߺZj7C aP/KgLQ<D/@kP!1މo꫙@-1*0?׍Qi `}ZE"!H)%j Ze:86{sҋA-RRԟ> dkǺ5# cQ/XSJ{lZlÒgH(t;V}Vo0%>ǵHU L VRȏ"멍)j96\U;au6HxFdHVD o7 ,;s(w|D ]wʬU:q܅|=?8]d#Ow33.ce[5bh%a`ҤM$CCkAE2S̓b?ebYѢ%haOTg)[5 ɣnjV&NzN2'e|d-QY 7Z?}ᰄu4]#u)pS7 '"@I,9}t /:YX4^P j.`ʳ®kfr%BM ,*F=,&;0K4ثB yW;ّiǽ~Ux,8` f"SEt֬:im˓C]Z&?U ]ȞVBJ"cՓoV*$xD/G tK$6ȍ:fa8pB{o%:2ښ/,B*<=^O6l˧C+bivɉusZ%;Ҫ9\ҚxG~뉼7EW.r4MgvjCRe^_i3ZE'Gꀿ9LF uH:

М) =ڳ< =zTKb/E~dMy:~s\hyp6U\Н(EܰQ<#,fa2/T*)ȎXfnQ N})꼇*W74H~p0>3l_=Pd^-~v"1GLf”f;},BAG{2 ?/Q .zIAT }* C%:KNYhF.zFVګ3{~^ıF/kpfׅcԥ{FSH%0ns f^̖SdkN;ʻ%TrZ`2 R@VɼnbBC75_e`244ϦӺZ<LպD PyFQOV}i#7K 3_,el3AFn$>E $W#ݗH"Rx,ӒSx.+'ss;lqxxN.' ij m/4dT|Xnʳ k5mO)Gy[m<;cTBPt={EidҫMҢ2;")ivh@#=<v9'5͵˕҉LL(߃ a$t%s/ŚAO_*ͣ3Feu`E,K!|ӏ/bs(e_4 Ol%OlH{DUzXgƦJm}NtA odŦ!~5o[JxZowWy@΄.}?k͇m֟ &,eƁڃ4@yl@[ƲO>Rv uŝ.Mnn9Ԉ$> [Q+†O6xM,6uN4ABG(bSgJƤN#,ϓ>!a9d,'H0=}ZUqI߹EGBb+t'k@\%ہ)[ 4yG r}߀GLs7 y#EomitdQDSw /zyߕ]Gmke۩},S:䃄Jx,9Gj?[[Ti%8-Ub4$ B%$8BH7Vot:&>#|gM2f1 ہ*Do_;[1N}}=kvv <?UsُYcпh_bªY# =Hg JQcÝ0Fo> >*H~mTHDo4^~{??U豋[A>Nפk/Q[dFqqA T'F /S磖$.b!dSK}:hw!uw*XUst\֜>;l8Ѷ:bPW+Akl<0.`9"a:efӝř7$oh< ,u *"6$ֳ+3QGG7_}|H1tҍtJ(֨=O{`CN-Q̆wCO5 [Tpõ7^VeӐ!\5˻1qhLAІ>nK $Jn}F٧t0etY]~AU 1Sv9PK9 'ƙ'sYorZ-j`lQ~0T[8sͦ,QBvQUChRњ4XAl<}i ƪ@3r(b0f9xmz[lT6#gHfMf~:Z(pJs|Oم^bݞ }/᧟}#᧟#H}ϼ bK }=A\" @-mʀqwۺNqZ.tڸ (WX0I3Qg.~u~6Ab FCP1~yV؈Bby,- H;S/Z3m?J\יH_#߼w 6xt|yzX|3ᘝi[+XC0p~jGYꈒ^zϽ,_谻h?[R_v(YciSoծ5ʝIr{  Tx-̀oP-F^dK^ed0c0f|!|(/{r={2g_6IW d%E?pGm:r6" bxyzHf&LVnز[OHehxM"MUdP> 5TJ˭/M5Ǽ8 Iuk봴}gg{^=w:2f8tS[~mfüI-xN2A38ׁi6(J{I֣Mc- !T:ȭNH=Ic@D 1^!pp^[f^60БQuQDufS2P ? +[Zڹ^zfJGqA(tKߙYƫ+_:ZZ )t\t 0>)g_ϑ)/?[& Xd"5YWC:Q؜NZnzG,"ʥѫKSf2%zE:륷!P(M˷0 MyA1!EzB0=2%ozW2.kz(% 9pt&Ų1,"M͓os"˯T=sӖFÕ7y,xZ ~I\XeJz;H-Gm3MSMj4uXrX~]< Ұ*F>$(!L Xesa!gQ [¸1l'a.[ك[M.xAd8w& y,HY˨ud_f$NЫc a9e_$+P.LW c%愘 u}c㸜G 8#}h1FMpԸXU-sWFV:.WVHGo"cA)NU<}R)6PC*/Q9}w<:wk{*O:?t"r6|iNWI$ꁡ ` t"2n4=L<$q#pyMϖSnvTRdtu봩gw/}k[]'hQsO"}h pn y䘶VX_(жlGŖٖz kX `^'#Wsmqnz(06~6IOi*A:aE=I\6jD,;9pr]ؙL' wEjI"jQ-ӟi 5>h4M1E3pc1diBS\lj_/ی8  pqt~A)f@h ǁ\Fz\BVc ,)ɩS>\U[@ -X˫ݥڜՁyghDG8 >Yċ'zEI ʹdBbH?nVJj_t [`=7S\DF[S:LQ ےCvK gѨlEefyaKI B,zte|Hd'M-ugզd\6sv0֏jDt>y:}SYul}΅-tYr"40SW塽PUw n׮k}|ނpK\ | 6r .je4($[sګ_P)m5lӉYYR0ŠB[8"I<CQJCJ耵ha%ͺKhgtlF=ØgTa &\)ܐӍ'X?l].κ\ػMpL$;DcpN]1I9TGG~k>΢uygS1ܝgGļ*,?i7; b,S낊T^FS,yg8e}.eZWv.7Dڑv)5ܽߴ&AAOBaEce0tIX$SЖt]ʧX :hÉ# ƫͩt4z1^uZ_5W&a,lۘD-+k/Fkgy*izmqS |$ao3g+mm"y`S}8b tE֨1ɲ8;u| x^ZfK*# &HUGwE?_$x5'zbc1C{nBݭ H? lP,J ,c_ƻPu[TM,xcK?  C S,eܪ]nuIJ6޴AϧxaɸmdE%}x)& 'EPXZ`ei2Kq1'No )%rQ+YzӼ5z_|}9e"I#:5ey`1>[B~֘&CSB#]MfZO韟gY`ƻ4[g}b%~XV!Kkjb<ՙVJeB+yp{d)z]w]xh&W{w:q&=L'CU?%j-LOŹhc!i6׍x ׈PglJ;~$C^A6ȼ4ÚŅQNNU% ô#{^\+6z 6@;BY)!vd˦zdm/̱cSvdGXJ4}M֥ =He H ad% Ơz7 z-"ٜ߭t}Y8^O9ANb6Þ6P׾Z #+]|:}uA(܇Եor,nG@掭.AR9U!s[AwI#$5C-A:}}l3bP7@Ab9sWL6\ZT-el/v˃u:aߝ&dMnN}Y1߬iNq $Cw 7( A]а߱ZAv4d^% ⟳|KVј&iqf@0AL:G(莏&s0UeПogLsj+byvuo%~PWzmϝrʐT%YSpJ”I/mM}ɦ͡ΌtuZ8 f06g]9*D݇]d1_43>deo 2f '$jCq^e;Jcc "Jǎ5\Soes4,ګ۸FD}p[=}NO0(IRK洚|@m,]u}=V+ f*W *}5w ,ý#'Ǵ. d Q6E:KzJs%Մƥvg_%ȼJ&G8.Fq:ɧ# tf $d& 7n<'u*+J/^X]"605| 4P&8,p,gL&\i~0ow7>?}&wd:<.&"6/fyah{'Eli6tv,`g(CD$Imi ²ۭЙI菜0|p챈Օ_σE~aj)s͜&YVVpY:;:ń &!67hp~7m]%x"%J8~Q j;ͩfȬF/U(gwfuX0?ңO۸D_Fj=(Fx֬$#}-|".ԠuYT4V683~}ȉ^@Wbה99Ujꔻ{^8/c?&:6Y,['aDZK2=1Fk\S: ,ISA UNDo ރXx%I:!.0V'U|Mn&5jos.*Bjiɋ!I -nrɊd E$ƘY H?58/$a(*i`Ӧpvu r>Xe<^tm?|o:PMIt`ZgQzSiM.)U[z#I$'@5(R?8ɓݽ N(h|8l$Pl9(#mݔ>-(+mZ ˀR#DƘgASM=br4MlxEqzw 6pu[u~VV-(n"^6׍_m[<4x+U νk?DMxE1Tze}mw0wP>YAb KGisZ^vU"ݾhy.!QaKJ`8# '&bq\|:qGc0HO]: 7zZ0of2X_{]52%2/'V1Fxzɓ-)ZЍu3"c#3s'-泴,;= Vpz6-Jo ]'^gho<*Z Aq6*vOO2i6>A*LMZsΐVQhL:=]#[dy=Gʧ٦#BWW[[ yAtV1f$Ѯ ݢ8D*kl rߺ/mzMa 7msڝi5.\ԝFHrGRp_}@}T&J?/w+z8̼=3W|U̜ypl"W5²"<dmzJx0 -|-E) pؾIbRKfF0\$Jg+ Gw`“4X ;/ ƧݞY> ƚ(GJd`] 9:fq߰ⲱ}W|:-j R5Bk4*smsU(BN"pMm@ȝEҪ&̵f0VgKuE<ݬ]qe'M7|\ҹ9OΡ/gq=]^E\,9Rr_շo, ۖӑwj]n.[zO=ۢuZPѰHUVՂPu-e:9oAQ1ce2E+?AW \}7]ħ/c5&nHgnPcbDn,uiv787MЛ{WaAWzh|1묛_5ۼ,7C;]Y~ਫ਼uz-hl㤛}= I4 -ڍn֙Im{b|xzՋyy ӻW!x+m?~HWj䨧Y?׺PMvl{_z39"sW7if mh"iߣݰu~ލga4it fio0m| a_ot˶Z؄U7gz/O#L7*<<U,Ӳ_i{;18n>N[qp{^8# <'LC;i @5^w5Cq3XӅQ,`'Oa޳MURUE ᦖzZT)zz3<@ʀ+uQkU1D'8_g:OWmFOUbpXtwN6 xND "i-ﻳjF>] _+v/Cd얃)~/o[F6NԃD_$sq 4T/{ćspz,HAk`[)Xgs|=kV=9b4-OuМ'Y *?'5'?}\M~^~>^^էWP`ӣoGm^4<^OѧOWw^}j|>|?|8=l4@鳛_߿:Fف"d_V#0 /F#ԋ!R`uMF׽tc.9^Lp+X&3n `d{^ݾ4y޼hܾnqCOX_TWfϧ>_gW/ێk¹ۿ{qfΐ8Kܻ]ptLvDd=%hL7 Z9إx ]xcRQ<~ U7j8"KUy Qhwz9u,O[f0eyNz>@1Q/q鍝Ah#/O[xo >́BGs h>aw7RUp|3r ):h^޾rWcuj0d7K^`г=q7w—Ij5vzz?DDyp;T*^|Po>×.n0Ӌdp}mw>\ ^n@&&$pdC9Jvv:JkJN^oZSi1lޟ緯F})-h5gˣ*< [nޟۣgCut,ޢl7@gHTq}q1r_l/Z5_*Ŵl[w[%$قilsQgaYz}U|ܟtEa݄-6SRGԿ>[2Vy3w8T;Ço㛳侉bwspc\|!wԆSu]l7"=?O[`.d>6>}ξ_[׃eOB t<\܁!>?L hݱ3CrL[#Oun8y@oO%@!mM%@;C˻![)-؍5 5h?mmo/a jӰ'H?S?bƛOdvZ "`{|ZSx߾ܢ! |B]S|{5$hy^ma+OGx ]Cp\cy)3(uAD]LZWU )m"= G3?̈is(]890-Ru'E)wj [^)g+DUN!D";Z}uVBVQ%O#XSHGd ,J+c&U<`J)d rBIA0:ZZE<%[1׾1)6~l7Ҥun1rZ^.-v e.3F1,HhzpTο}Ro!B!#@,wp)+[/wMGs]mփޠ"{ϿAvh]zsB6ltAlN_[GLJޛz1G${>oݲ&jESyM,GŁ7ݿQ{p`r¥zAUї7^LQ} M/Öu`E> d~hb`⟥M ѿ ߫աG(Wr>S͏N|Kwo~OW~G yܛ^kIz\Wgei" 0Φy8Pxe!ӿ >r/O%S"ʑkI}0$8U{ί~#y_7H464_o/lUa.Bxhr ,#.`s2"@ ;dpo"tDB̍e[;| og?rF?~p:/"POFq'do_!,Ӌo0f2Hh8dmƓ.b/?_.>&J/#׫!ݥ~+$ #;=dVDQ:wj!XsC|zU^{+}A;L4<&X rnGx ԽQ\m DB(Gp)2B'D` +`Eh2S5@ $ʗBڼ]f`ТcK;t{;@ůؙ<2HZ,1(X~߾ղataP=p_dJ "(waAW5UDJmDKH3 !S(tNnDeKԺts|.Tp޼kK] fzR26AZoTۥ+(P]g!Vh8,T&2H41-;䓫@uJ"(4Y"׋LEVI<+^H˳}}M}:OrQk.e_m1yȋQ0+Zֳ~#PQb_>Wfw;8Z \>L׌cߑvCOA0.MkNwvwp^din`cn3~{@A<<~3/>h";ez;q0dewKVbyЉt1Y4n5.Dۂw1yp^Xm&$~1%#Ge}{;1 >~lL~U bPvTv8q1nƗ1\|K?]]4/goo^qpl?~ǩ{{wݾ}5?xws_}qm0lWۋ yS~sKkS~1/A<9]n_-^Gj_fo/OͷzyvpJMj?&TS=oo_OE Q7bc^<]H?$?o_p\wvm\K5c.I־?2MFw6< }S η׬ݔ.G`?n5>* .M!pؙ^\tnmվm>/6Ҍ>AqTß~9Ylmkᓷo϶7ߖcWϷۇwmlH٧oڬםۑ_zpexN^Ƣqӻw4<~+ F|n>pZ=}y,q}:X^_oη{ip51@tWF|?_2:mޚ{\w||NF|x{7:@䫱_;}?|i>{u|u4ikAGpuy>FtPS_ﷇ?a}g>׼4foFPSeOS?u|x9yuzc}o_mL_<4 ; ozp|ܞl@X_HwyH!=<{QI?ڵ''3~}xvspl;ip׌tW6}k{K|{C\V? ?޾LhponϽ7}!xxp4m^nxr?u^_<_~y}go}l]~noO'߾w1^|~ټ1_߽tϫw7_/QHg?O#BWaL>}v.no?4߿ťw]|pxL_'G|t~239_wY7NRhEyp28h=k|wο؋{ʗ_}u0 OwשQWft^uCӧoo3ř?ߏmt9{Nwξ]: N/7adv+I&<:o\%>ޝݷƇo-A̩i:_| $|}i{_^z}]:TpԇC'so{؎ߙO=ܽ w߃_k\_pniK8͋ӷG/ywq޼zVut޿͎ճwҷ />4GOQ:7^}[BK^4ۻZ|~;R_;/'Io$>ۜ}|z ՗އ%uQ27kO +/>|3^iTJdzAc[w0H>W׃ Qw~0epuvxx~|4ۛw};pZ ˯óai%R)x}R%`E^5lh7?Ķ d/ :`A:W/'=LLg7NdL8)VGn]",얚wfhUvas]_}.y%'}UN5> e^Us0b yPbJ-ׯo/ ڞ}{,ooorT1%y`\hJ`4jx'e5ɯ^$;x&t Xڶp/q8bd3]4yK壜3S]4Dd9]9̜V`8L "wR< .7gJMl}rl?޶\KXowAN.pK&< *o9y;M/,\`ULZ*UB"ޔg}YH\el2G Ɉ53 [7+Px)ࣰ>Ws׋,3Xl&\:ſn{pq&'܈_Q]}b{ >EzZi+??TM*eNSlswAޱ+طw& Lr8P\3ߊȧt2KwQ|y7 {z?~ޛw%g::h@gw)t^=&[~_Ƥ0N~Gһڥ͆H*œ I)tWf{:$X%2+,{A7p{`+/jVm0I&AP8_u?QWIK"KX_zphp{!iSi/66W747}/qCչss$P뵤UsFwUt|RoNN$vojޏDBQGAX1:MMJV1gԠzV, =W?M;j83cT}g5{{%Ff zۉeo٪ zaw(<ɢיOMEm9eò&ivo1)̻ZG2_[5_QKOf0N"Mh(VW^搪 I BwPg'Un4$iII{ 4h5qyN& S/f+Xi#|;eޘ1T{Z gѴ;ȏ^XshG܍aw &C괾{EF]?J#;ƺS68G;n.]QHmdkgY:|o"_^4f*jz4 peo~KoR߿;.|WZ hIҫׯ5 ޝg=vӀQ͝W4qfic {rka*tR-Iu,l-K9evMY{/PuM@yQhT[3y1V}c`iC/ci0H;Ad8zV6 mV@\g#+|R,D,J=+P{o9Dy0)`h J>N ͣ`IvXK&'(e4U۶L4,\?뙾uFZ-,cXM%Ղͼ ˠN{ןf0wC;3S?\ e "ˤ4D>_.@;c8M](H<݄e:eۃ!Ī/8nҚK~sXF(Z~_,kckM«OWwATSƉ $^ڦ$'1n*N6["&ݬOBG.9-:%r횛Buu1ݕ:Жrϭ7 kXLfV6މڮ ^w͞;bX`bހ4 F?eQOrjM95֒3z6]rUXYE2cyK+{̍h؞3>@ף~>,MIV2X9K&v*!{ zͳd[߬gFb#+ e mljL`]@e$؍ߧ_;?|BIqʪ`5w |ɔXW1Ĭz5˫ !v-,dkXc%@q6]̽\o8 7@ '`k/;*u R%/[m$n&ĿC~ݤFWu84PFuT Sʄw?өO2̼6$?='?S^żIW` COP*/IA(G\!Zx(hj!;`M gekaMtd [I Uȟ`q~Ӌ?iTu DE\$r`rkѺTSж\mhDY`)+!¾;/ٺۛm#7lM{U+pp0v68mI2M]#P0ó"`^a&]=pRhj¿KEG;fr ѭ6'h?^S5Wvo`,azBiZzab>!Zw,";ail>u 1T(V "QCPyw!,xاγUiP`7^#nU`vaydK1W!g3""Gs3%|D!&° {dt"R$2?Hg"UhKWQȒ  +kUD)"ĬT P rUWIh=Au o0f"w ȍ0XSZE+*8رrVc9b6UX0X.܍U1t+'Q=0yBCm)R¹Y !Qiy˅sϝ A)sJB0n;0RQTN 0nFeYoleSآ(2oꝺ*jUeO(vVa ,"5ta8^_ \pRY4&z/ YF+d \ l~UA`o DZu]-Hߵrjv& 񴓢ЁQH,bo CD{"*C⧜NaW)N;[+jUK]32W);JMMAk,%W( IS~\!}h6Wn.axpXyܥ*2stt0X`f ayq3Kw*:cGN德JtyQp A8lt ke*X x;3^Nݣ؍c+RPMxm j♱4%-\F-nNԱrjO.*&ln2!PnߝFÁtfgޠ~='zDAF;4ǹTNMM"HEN '.Z'i `x&*=n6e8ȁMR ,-8l=u?pׅn؂4[+c9D&Ghj:6qF])/a쫇WXT K]8]̜`k 0Ǜ3ò63vp& QVeZ0 p"ڵM,R.tu.6y섮д R] 7ҹogx~vj4r5懗AܙRviu\aQ%Nk( Lƻ5_[ơ=G'T1yB.?'AuI3gcm|j˩NL%#U4*5)oSZNuJ+\/p GOVc, }z oI\dMGj:K@-.bhNt#m:kl5Ks2[.N/ljfLQ4ռK.4 r"nՑyV(Q3b.Z ׁ\(3Xӧf!zBQg)RL67.2v7"1ji`uzq{8~x#-xf2j㷲?#\1?dyj ,7׃F<0܌l^#, -@43E 0] }UxMm&Rs؈'?Xۼ+Xm{p r7wxE^-̷jw=enbtMМC4ᖉn(jt:|͉<{z!jfy'ꆃ -uo{'(S~e+* -Yvys{(fkc4f/eg 3ڵ*h-%?/;7\(HOSgN WPzI("n6 tRUߵh0;ݾmcS;?.UPL) 1uu'TFUj!5^onu9ݮK9ϖxE-Sč „{ M-rk D,7==  uQB_ϝBD` Sx^ט}|މv; (pWK<\X<$,e]jZVo6&`ywd^yd7bz-MZT#JQʁUvO}P`GYgMz.P-㞙jY긾*4'ذ;0Fnͷ_84QGz6F7P&]=oƮh4̣}yBU+WfU#,{Coڛ~W-o ]g⡐KƖFGsun0L ޮt*7'u%|+!oagjDR!ȳS3*iFU +o[qATgHEM+N (Cr*](Nf51O OSY)F{?  y^$^{Ya6_FH_ n}K3 +Q,U,;C–JKo%yL$|p}#4}0LVX )&YGeGIch2D \8" ZҊ ,5@%)7W-{E>h n`ě&ҲzhtVXlCjݙ5 M69muvģ/¼%0C*KocOF^VCOez"D$1?;`6v6ęfޝXzS7ڵ\׍돬Qv”8Rt&\DH`H ?ͩ8]A:sG &QK}O6TRrKµbaLh/$U=IRZU ΢TI"vh%`R&wʑ BjGbGk]aIIJJuIB47ȼ*|sy$Up^dN UE&賅K{Gb4‘w5`- -: yB+Z`Pfol3O MGfI!6#dqzWGx?t]uxn92ף!!$3IJ1? ㈓|FHYCQO&Ap(c?fؐ h?&!%2JFE47a b曟iW^CS -~釹 s; T&9wn6Mo&)ȴ67gz\NԵBdFl`>ll :vr #u *$}xqGd#uA8dA-bH+î,:4BOGN!ORh7u? >}N04v0:.1t:#G/D$6gSoF )1_9nԡw0mA!+8ƦaUu.[h8+&v\NA|urK2J+K)zd4[2oTtCa/(@x~g/@mnHV C7&k4qM1 ۝.{6v`؟ᴀ{Ù6Qr T!3³ʵ$`O #R3*OPe1p͖B[- :|-wHbiR$=N@̓LH[.\^Qمۭ^p{,FVWM!%TgJ׻Yv|q|TUz!z `Ub8N@D!a bGQ&A=bHiP&]GX=hpnFԫ[QT ᗩz񕮥fj'~*,f>_39JEK^U@A^6߳'*&n'AaN{D[ bGei,ҔUog_ hH >N++Ƃ_㪫Jeܙ)r433dЍO*)iAOIA2QNqWf M_Iݑ@}Hd) \6HLOiIxi L7$G:`imVpƃsƋ-q*4=A Tl24~< +8lTߪ=$prz9'au4mF:sC6Ul3V}H${khVk(CMNܬys4(+jK  QBSs; ķroѠ7Ri7+jnԩ(hNo@8тRB74{$RP]HYyO`l@vlHFǘ g`,%JsR&, +{%Tf jDPRϥ%DvMT,o Ng@A< -qP?dfd.!囝+T'Tfp˥6|W\Ffro)ӆSB97*;fiBsr-p], RBRPȠUoP!8m" 0U,] oί7C C)rN3v5HuJS׻AE>xJuE) +=Y!CXJƹBd]@ &i VQQ 0KM3J<3 )[OD/ J?7W8e􈊆xQE̍+,=:u] :˩Ab-(|ebaGeё%GZ7aDpϒ{ ʘM.D5D27LoLF"<ԋ̤Y8s־b$?ߦ ](UFn$#W'42|e h4P"wŃOUT~a>*1ExxaCk39jUedETSj8/$"o=5AU+V|RJL-F _dPz^\--hn$|" L%'Ъz@R&W{/_Hغ wf<ޢ`„Ap̓w{۫ bio]694§/XBVEpId0:VsgG|S6$t(;U GwI tNTKoh,A1i|̵[aS/-ӄG)4bWD$͑B'n=kË9 /!܉[y/ Z.-W1&:b@/rqZ|\pGȚ鞀lܡp>| L\M-9K.-Ex7]W˱v070؛(dmjܕVFG1ej6Gulo( {TIb^ sMSF 59\st[+1{)َ'[el׀3tz:Bea!$ #d t|}*Bǀ%9"{{57ڸQtRY3tۻ; " v9WJXHGs[p~X2nBv=뵸IT?'DZ+Key,T(L۶c O [pP} U,D*b첥e# Q9bu"1TJxYĈQYD-hbq;1Yԋ\fr,RzsIOI/#"Z4t,u5b:Kg+1ʉsg64cbREAyRb@ϮM- kiGdy;(2-.3 )MVmɵybD GfKxS5|pbeƏ$¸q.4 |a*_/Khw_]WLNRRPQZ3-kI]>%?잔[T{~DY]JK%l--Ko-;ipAGNdz;CYدjÒ'nط'"kSYd#] S7wn /]?nЗH ^i,_ѐh[_ZEFNtG]0RԡUYFacnArO Q,,a\s5Ur7Q^2tY̜M=U:*( < %z:Q %N kcs=y{a3*'6A{!,E4yo6`މa {{cWo%̝XN5Kuv'EfYs(p:Qެm1M*._vebztbIط˕ ( i>#_?]aTyQDHd?p0G3\M#f4a8s(]d`Zn+v3E2q@]))t`"w "aߥz +N^D/DL6J)J۳OId8sƙ5hp:feRuc$Yg% B,7Iu.' m`_hcpS;icEHÃS.:vXGr>ˌMGF0k``]c5`򝾞x6 kܕ={DGXkf訴Vvę &,*vmi8]q!{]u :Y;Wþ3A AXGob&go{{{TJ0qTpZ5FM`ԈȈwcϭ(`ZƅmIAMCwW|3h݄wJm.{T@XlU S&)p6iա" |(4wG)?+cXacR/Zu 81C]G.q͏aEč_~ݶb Z-?Ł871%%߿) r@𕃡͐jֆ`EzWǯ6[diG>^PHTF>LUYU.ɢkd5!qr^xiV6i38X4x-R;7"`Ul#CV}Miҧ1 ;raOBORL2r4(MñAK!uJJ|1AleeQ"vh*yLCp(B9Fl\GfI+ Im1_gY;4(/dpJWf# k`U/u/)?YU ojCugX2HX56' _(4ݡ[bl wsZ/8ƴ;)GN䀟mlL5ʅYבؠ,AD'0qzQ(SYZ0Q_Zn_?代f±٢X^jhAYk D cKeCs>]*j}ǖ᯽X$<)ГułzP{?wk6 /øRO[7UY8J]9KK6O_њՂzqt., P±k y>+g؄ڸq ĤzV;DZ@ġgj&Nu-8`|zy^dQ&!?/A89諁cV/>Pтm:lÂehݏ|uRg{{Ro˙g_y$q]!zQmPR FmaMV+,"(9F\^xܐ w>y+efҟ#gj(XBuU-=R5<TsS*:5#JV5np6Bwkz)Y V&< Е SnSN-}扻E+ Z⮟mi^-l0$_. lʸLBKI,"8'C`r{!Ig9ӔQ,憶I,{M`rTh86h}7>EM]Y[ǚ8٨%!NN!cU9"#-۲s3n8@nz9e1У(Yo6u s-{0 ^rTa@9,֪s6fi"6&_a'tHtPt2!_y92 ӑ[B-FUhԴ‰1U s0ND"W A, ȁiSwi֙\*\q".G#Tf۵Nƙgq (M,̔rj/ U7[0`ot</3qF|yXѨd&ӡ0מ2޹T2FMǶz:-Pt 6`1簕/NYB@± s`aOe^M(|2{(3<<bܠyF}OPNFJktg[C7sKT&쮞x= W nn-oCe@+]!;¡7p&ahMIFT9єLeMx CI(m { \ˣ4SdX8NY&GxXÞcIh5vd`4Tz~Zp˱; 3l`^q+2˪Tܗ+,<p1P3OĿDN$"j`x~'1g3&ݝq r! ׭gRwb1k3B4!h>9I7eg>toƽ&WG-NJ\係^&Y"98]A.砂P*c`jd&3FIf *h5l^ .>y&Ѥj~ 32CpNFCM@f3] H s5*Sa"TAZyOy}( eе8:5reh`o-j%~9yǗX`{*K Kw,*Kk@e<溨h|Y@XjJ?-}G$T%FύDŽ Y!QN??׀'ځ^n09w'*2r-'f&(ݓ#S۵^2֧,]ΕAiGq8wDqo$ӹ!GQqhdFm[9yO Tbiגq#6\9)l<v,sЃSlv*jVIRJa^b ZEz0 _AIKMnIݺQ/HrU֏Dz(n4{,&[M\WF6w5 u +G5n kxrDQ*ڦe\)irB$ LXz'Bs%!5Kt[`폰 kIxQwl\j`uW(>ODVb_K̵{tWܠ%iԱ껳i\3OJ,}no&:`eF(ȟ PwQn3vIJz BG:vf'#s QJ3O߱Lj eF!xRxU+|afTЧrXc pyk"VݠkCAQ*S@)LUȃz; v՛vy͇xLMGr 8h'WmcQr]Yv?ֲ(zOkz;Fv|yaY;~4>'ГȖ~2!"$ ((2g ](nNSc.fJ 4V:I7w4=}DzmϷSqX՛#@#{BOhm䁊a &Pmh@CGv-:NuZTgix”<4OX]M U.80t!Vn&]5NL/xz*jqx-~m"$Ez,/_I'nDJ8ؓxBͩىNtXu-=?sr8si.};zAZ4uQα3'*[z<⺯y%Nj#JqqԵBTIWu2 >}r@n^;A|w%* =G4j|0ŝCQaZ%k]zļ79Myt_2XfI-=6سYu/ce3r1v^XÅ{JT<499tp]"Y 2v?_*t`zm(e^7OK<\#OEt@{eD8% !A3싍X]$s=&&#x؆Zr/%,ԋvcs#ĹJ2x%@kRQHA*CDML-;q<ňN!n%񷮍hVOuM06TLHo1<`zu L&0cŪTyNy_!W(qv;o䶀:#ui2mv;ei`O|ltCc\i"#$B\ݵgXh$J⮉3ro! cNBJk¿Kl2Śiobdu|ӒjT]}_ lZ.*4A !<ңp^?ќMB:b:Et(E~-<<2`>G÷իibΝVM%Ǡ1Ǜ(p:׼I/n#4ogImSNMJIff50ed}lakDC$ @~T6XtgJ^-* ődwF8ßqH(F.~wY#^[lG:Bh9F SVMc>6zQxK -n:95&w"0qqqL_*Ld}yj0＊ Qî]iRg2\nƭ͉p]wM5Q䆴c"Sp緺ZHY~LU˪ǔ$\xf]qbHtt ;&gyH14 ulW?i#2Ƥ_OBE"TlL&KT:\Ѭrqצ$?5[wZ%w7YZ$˹\ӮI H&]=a!q}UK*'wu0AOd.%F3)U=<.4AJNJ_;VI7pvJ3rYEky35AD 6 <{w6$200]˲0z_f\@Z+K7Q;Ù5B~xeidn|l6F2Rщ-d9j'fg3Y,'[~^nе'-^NnǁNbyJgzPZm7FHK@k@$Dʥ]k4yU"hhd5AXV)sn x9FQyXJJ\|L*ZVz~XMӊR:$%sy v1[1+D4wt(KʏЧ`pG(~@~w??6h઱frrk*-op~R %oG܃6g'>2B,s&hZž_)twXi8]fmYo[Sݣ`4JWJfY9ݤ~| f%ݭi˅ꆻ͡Լ|-(k^mre0]*OgGcS~9@zdZԛ3}Z.'\ké2}ul"ׇiFk+]KbNF4OqB,{'K+f X*daF[HY*<`s*` B]^؋ u}R>6cO< 0wzqSc s|bΖ3IôcXø'zH{ajESG5 QחL,7`L;c_a6aHp0{ .c`uZ{@OI'³Rǡ `-Civkyt7L] c`hrr=R{u4Jb_ڴמm؊kFoz״ ]@K*fux$@S+0`~1~Βֽ!2QYV* [hO"Z1Vy`WCMޕyUrpŁuƴ2/y "Zb%;ԝLQH_/K:A樌^fc]:j"L>O|jQZ.m+7Ы `$eUz:įO&E3:Q*MhT`۶'d<憙lQ]k9qc1t*Q(Ў]/\bꉦ3VsZ|m1Hm8_8.Y>XMy .կY٦nUDHXϡNs &>,-K-IvE噧qJ:嵸~qdWԒ`9bb'YLdUƊ\D7ȹ*HgƎml|񳦊vڎx S ܁M PڽJ<Ͼ )4]"G_¾Ld&jvNiq{̝Dka6BD,<%dCV_E FJ8 hH<=,1 Ex^g"эj=68R#4 涥-~INGpdm:,h?ė#C@n$)8X`l[-ADBэBG(@M׊pzgV5֥U"ͳvֽu)Jnj8*M<$8 3 -7<.Дu3JrӐ_X{z& ťN0,is uQXvDP*0ddq #?ڧĞPRCAeN v TV_dwĎ TG<5`%=5=n(zȯx];h xrʺf8UX׳pV ׎ל:@p`tRS?a¶籗mxeUFR/wpG1 ]m G4dԵKmn{2KN$̵ZdZjpP m"ljnG)WYƹDmtℹ4F+0_WF}~pc4WGÙFEjԡi) N~(wґ\L[$02 ЍW- 28&9.ڒZe[$+v*|ܪc-p,?td,f>gQ6&.j82I~Pr~m|OJ+N5D%c&n{T &LB@9^U~+2?T(/!C{EBa>WA#m(j2 ~7ML<&/- ֦슠/=knFWxRMN@t.sfӴӏ,}d$(` 2sgEI}1 c.1qDF}6Hd\qO#(HQ:,g2H<P^7v፪]LIAԤʣ`[U2R=b[˜|}(u}Oi7qRF#={khz=`!*RR,N٢*)t+lr,cB;AodFyj]}}3Mh> ֠tz E6 OV'T{BVUĐ% pIj &:0h׆QIiO 5N3eZRbAC}uWS " u:& WiwqP# ŝRiL˄2OJLFVv%Ϊ'&eE*[6_gYl >aIaP8V 8z-^̂ꅒRܐNaR:m\du%G魆$fr7 &C4E YM4]::Σ6W,ghZFh"C ^Ze9 v_ݔZU;ł?@i7En^x?alJ>JF>ƌLZ.Qt<7uSZt1r=XvS6=m`dv l|ŇGȇ/_'!2nMmRps:w"x:(G;GD7 -8iGjpBciqrC/S # z+Y]=9aV<ދ_n8u @: S ngVw y#-vegAlTxJlc)O|\D #g;CuSj>N`fvG0s t² Xen sXB9Q;zYdl;MהSf9RpL'\M=qJCje]s;bXˈg-n=y.J+:;j gi-˅#@%Y=:MbP_O ͢+:-(]ӂZ5{:̅̆ *l*RU!Ȕm /s͗Yn*g[6r-2%Zx!-x/۲#2m ʈ2q2~'Cse)I% 5Se{1Fé:Ҝu'L`ue9gl=ȆSFIC皑* mX)TW`hSl>/'`Ji7k%}ݑd{^f.H9*. q?YP >64,\?뙾uFZ)JRꎣ46EXGs-2_VIE ʲ8aqHd4s?\;!V/J{J4OÙެ<;5N3f$ˁ33h aj \-@Jzǁ% zkI˵) ͌\lHE36,팘"N!,WlxbݍxZːBv 5E8D6 c5:ݾtWE]iipm1SwTru™Ne ' A>\&{J[ۥJ} .Zۯ#C*<hUSs[(2}(SG?FIIX"i&Л jqwuVra[dX0O sUp$gv )s6QP"4=l?"zkkt):)(8.컛uu^ s@3cq~ <_V وf(@"AwH/h#.!0*UNP7a8=G+,Y-,:bnFzPXE 'fS 6+d%$8j+lj%'xOMU-mijHNV(eϋ?ps16Aޜ8"kˎi~iO$^;-tuUXjE8P`c4K#QA)Δ$UWf!Sf,Y-P%tda#M@8 soWGM``.=b)s s0T&^ \#+W@?1=gfxSukOD`!CB=%1ͻVq -=qQ>\ U& S9`\t@Vr~*4.tFXF~ţDΘhX_Vv?ƬXս+.1  =rǬm\ fh4U; BzلI"M\U;ܣ<V" .ηL3JNv͖ G. ܔd_Ytb}F+;2kz%_di0pZ~0Rx #$B6p"#1Ǫ$VEXq 0q*.&rN )?~~b4"hOWMG̹P:|B*rHFHuqݛr&jF" -%{> U$o nԍ%JY Gr2Շ͗dR5 }lm}&iL7X4K`rC>'R ,b6_j,84]Sf3Ls'D!4ylGxgf0{x5 "=UVoI1($*EgïQu&%<L[9:TI&ѼJќ-G+xA >-=TߥEq 𪇘"*!n6u\ NFqHBL0(jjM)VS tuL YzSuTF|! x4kp;fA@ }{Z6Z.u0LlO 4}ب'īN矋~t^Dϟwy{?:xDe?p+dmj2@-ٸW" Q:$ԟL؆t eNF)8)@Fn ]ɂwi/<x 4Nt3Ss"2`{Lzh#k:5 _k_qv1%w1EtIgdOfފc $]^^xnz g{5`L9 JgA`&|bz~S}e~6`^^B4}pCt7 1/DRl iVgߕ3@\ |#oP+"o)\|9{$^@jY/ج*э8N[wQyd;0)`S${`WtOq➒7oĨ52JYۦ޵XqT6. UAΤ638f1~YFnSQ;yL*Vqtޙ )v`ðT_~_yQaC4Ѕ7<)+: &eF"z.ēߺZj7C aP/KgLQ<D/@kP!1މo꫙@-1*0?׍Qi `}ZE"!H)%j Ze:86{sҋA-RRԟ> dkǺ5# cQ/XSJ{lZlÒgH(t;V}Vo0%>ǵHU L VRȏ"멍)j96\U;au6HxFdHVD o7 ,;s(w|D ]wʬU:q܅|=?8]d#Ow33.ce[5bh%a`ҤM$CCkAE2S̓b?ebYѢ%haOTg)[5 ɣnjV&NzN2'e|d-QY 7Z?}ᰄu4]#u)pS7 '"@I,9}t /:YX4^P j.`ʳ®kfr%BM ,*F=,&;0K4ثB yW;ّiǽ~Ux,8` f"SEt֬:im˓C]Z&?U ]ȞVBJ"cՓoV*$xD/G tK$6ȍ:fa8pB{o%:2ښ/,B*<=^O6l˧C+bivɉusZ%;Ҫ9\ҚxG~뉼7EW.r4MgvjCRe^_i3ZE'Gꀿ9LF uH:

М) =ڳ< =zTKb/E~dMy:~s\hyp6U\Н(EܰQ<#,fa2/T*)ȎXfnQ N})꼇*W74H~p0>3l_=Pd^-~v"1GLf”f;},BAG{2 ?/Q .zIAT }* C%:KNYhF.zFVګ3{~^ıF/kpfׅcԥ{FSH%0ns f^̖SdkN;ʻ%TrZ`2 R@VɼnbBC75_e`244ϦӺZ<LպD PyFQOV}i#7K 3_,el3AFn$>E $W#ݗH"Rx,ӒSx.+'ss;lqxxN.' ij m/4dT|Xnʳ k5mO)Gy[m<;cTBPt={EidҫMҢ2;")ivh@#=<v9'5͵˕҉LL(߃ a$t%s/ŚAO_*ͣ3Feu`E,K!|ӏ/bs(e_4 Ol%OlH{DUzXgƦJm}NtA odŦ!~5o[JxZowWy@΄.}?k͇m֟ &,eƁڃ4@yl@[ƲO>Rv uŝ.Mnn9Ԉ$> [Q+†O6xM,6uN4ABG(bSgJƤN#,ϓ>!a9d,'H0=}ZUqI߹EGBb+t'k@\%ہ)[ 4yG r}߀GLs7 y#EomitdQDSw /zyߕ]Gmke۩},S:䃄Jx,9Gj?[[Ti%8-Ub4$ B%$8BH7Vot:&>#|gM2f1 ہ*Do_;[1N}}=kvv <?UsُYcпh_bªY# =Hg JQcÝ0Fo> >*H~mTHDo4^~{??U豋[A>Nפk/Q[dFqqA T'F /S磖$.b!dSK}:hw!uw*XUst\֜>;l8Ѷ:bPW+Akl<0.`9"a:efӝř7$oh< ,u *"6$ֳ+3QGG7_}|H1tҍtJ(֨=O{`CN-Q̆wCO5 [Tpõ7^VeӐ!\5˻1qhLAІ>nK $Jn}F٧t0etY]~AU 1Sv9PK9 'ƙ'sYorZ-j`lQ~0T[8sͦ,QBvQUChRњ4XAl<}i ƪ@3r(b0f9xmz[lT6#gHfMf~:Z(pJs|Oم^bݞ }/᧟}#᧟#H}ϼ bK }=A\" @-mʀqwۺNqZ.tڸ (WX0I3Qg.~u~6Ab FCP1~yV؈Bby,- H;S/Z3m?J\יH_#߼w 6xt|yzX|3ᘝi[+XC0p~jGYꈒ^zϽ,_谻h?[R_v(YciSoծ5ʝIr{  Tx-̀oP-F^dK^ed0c0f|!|(/{r={2g_6IW d%E?pGm:r6" bxyzHf&LVnز[OHehxM"MUdP> 5TJ˭/M5Ǽ8 Iuk봴}gg{^=w:2f8tS[~mfüI-xN2A38ׁi6(J{I֣Mc- !T:ȭNH=Ic@D 1^!pp^[f^60БQuQDufS2P ? +[Zڹ^zfJGqA(tKߙYƫ+_:ZZ )t\t 0>)g_ϑ)/?[& Xd"5YWC:Q؜NZnzG,"ʥѫKSf2%zE:륷!P(M˷0 MyA1!EzB0=2%ozW2.kz(% 9pt&Ų1,"M͓os"˯T=sӖFÕ7y,xZ ~I\XeJz;H-Gm3MSMj4uXrX~]< Ұ*F>$(!L Xesa!gQ [¸1l'a.[ك[M.xAd8w& y,HY˨ud_f$NЫc a9e_$+P.LW c%愘 u}c㸜G 8#}h1FMpԸXU-sWFV:.WVHGo"cA)NU<}R)6PC*/Q9}w<:wk{*O:?t"r6|iNWI$ꁡ ` t"2n4=L<$q#pyMϖSnvTRdtu봩gw/}k[]'hQsO"}h pn y䘶VX_(жlGŖٖz kX `^'#Wsmqnz(06~6IOi*A:aE=I\6jD,;9pr]ؙL' wEjI"jQ-ӟi 5>h4M1E3pc1diBS\lj_/ی8  pqt~A)f@h ǁ\Fz\BVc ,)ɩS>\U[@ -X˫ݥڜՁyghDG8 >Yċ'zEI ʹdBbH?nVJj_t [`=7S\DF[S:LQ ےCvK gѨlEefyaKI B,zte|Hd'M-ugզd\6sv0֏jDt>y:}SYul}΅-tYr"40SW塽PUw n׮k}|ނpK\ | 6r .je4($[sګ_P)m5lӉYYR0ŠB[8"I<CQJCJ耵ha%ͺKhgtlF=ØgTa &\)ܐӍ'X?l].κ\ػMpL$;DcpN]1I9TGG~k>΢uygS1ܝgGļ*,?i7; b,S낊T^FS,yg8e}.eZWv.7Dڑv)5ܽߴ&AAOBaEce0tIX$SЖt]ʧX :hÉ# ƫͩt4z1^uZ_5W&a,lۘD-+k/Fkgy*izmqS |$ao3g+mm"y`S}8b tE֨1ɲ8;u| x^ZfK*# &HUGwE?_$x5'zbc1C{nBݭ H? lP,J ,c_ƻPu[TM,xcK?  C S,eܪ]nuIJ6޴AϧxaɸmdE%}x)& 'EPXZ`ei2Kq1'No )%rQ+YzӼ5z_|}9e"I#:5ey`1>[B~֘&CSB#]MfZO韟gY`ƻ4[g}b%~XV!Kkjb<ՙVJeB+yp{d)z]w]xh&W{w:q&=L'CU?%j-LOŹhc!i6׍x ׈PglJ;~$C^A6ȼ4ÚŅQNNU% ô#{^\+6z 6@;BY)!vd˦zdm/̱cSvdGXJ4}M֥ =He H ad% Ơz7 z-"ٜ߭t}Y8^O9ANb6Þ6P׾Z #+]|:}uA(܇Եor,nG@掭.AR9U!s[AwI#$5C-A:}}l3bP7@Ab9sWL6\ZT-el/v˃u:aߝ&dMnN}Y1߬iNq $Cw 7( A]а߱ZAv4d^% ⟳|KVј&iqf@0AL:G(莏&s0UeПogLsj+byvuo%~PWzmϝrʐT%YSpJ”I/mM}ɦ͡ΌtuZ8 f06g]9*D݇]d1_43>deo 2f '$jCq^e;Jcc "Jǎ5\Soes4,ګ۸FD}p[=}NO0(IRK洚|@m,]u}=V+ f*W *}5w ,ý#'Ǵ. d Q6E:KzJs%Մƥvg_%ȼJ&G8.Fq:ɧ# tf $d& 7n<'u*+J/^X]"605| 4P&8,p,gL&\i~0ow7>?}&wd:<.&"6/fyah{'Eli6tv,`g(CD$Imi ²ۭЙI菜0|p챈Օ_σE~aj)s͜&YVVpY:;:ń &!67hp~7m]%x"%J8~Q j;ͩfȬF/U(gwfuX0?ңO۸D_Fj=(Fx֬$#}-|".ԠuYT4V683~}ȉ^@Wbה99Ujꔻ{^8/c?&:6Y,['aDZK2=1Fk\S: ,ISA UNDo ރXx%I:!.0V'U|Mn&5jos.*Bjiɋ!I -nrɊd E$ƘY H?58/$a(*i`Ӧpvu r>Xe<^tm?|o:PMIt`ZgQzSiM.)U[z#I$'@5(R?8ɓݽ N(h|8l$Pl9(#mݔ>-(+mZ ˀR#DƘgASM=br4MlxEqzw 6pu[u~VV-(n"^6׍_m[<4x+U νk?DMxE1Tze}mw0wP>YAb KGisZ^vU"ݾhy.!QaKJ`8# '&bq\|:qGc0HO]: 7zZ0of2X_{]52%2/'V1Fxzɓ-)ZЍu3"c#3s'-泴,;= Vpz6-Jo ]'^gho<*Z Aq6*vOO2i6>A*LMZsΐVQhL:=]#[dy=Gʧ٦#BWW[[ yAtV1f$Ѯ ݢ8D*kl rߺ/mzMa 7msڝi5.\ԝFHrGRp_}@}T&J?/w+z8̼=3W|U̜ypl"W5²"<dmzJx0 -|-E) pؾIbRKfF0\$Jg+ Gw`“4X ;/ ƧݞY> ƚ(GJd`] 9:fq߰ⲱ}W|:-j R5Bk4*smsU(BN"pMm@ȝEҪ&̵f0VgKuE<ݬ]qe'M7|\ҹ9OΡ/gq=]^E\,9Rr_շo, ۖӑwj]n.[zO=ۢuZPѰHUVՂPu-e:9oAQ1c Medical Writing – Cliniversity

Explore courses
Book a Demo

What is Medical Writing?

Medical writing is a specialized field within the healthcare industry that involves creating well-structured, scientifically accurate, and clear documentation related to medical research, clinical trials, regulatory submissions, and healthcare communications.
Medical writers play a crucial role in translating complex medical and scientific information into various formats, including clinical study reports, regulatory documents, journal manuscripts, educational materials, and marketing content.

Enquire now

Career Opportunities in Medical Writing

A career in medical writing offers diverse opportunities across various sectors, including:

Pharmaceutical Companies:

Writing documents for drug development, clinical trials, and regulatory submissions.

Biotechnology Firms:

Communicating scientific research and product information.

Contract Research Organizations (CROs):

Providing writing services for clinical research studies.

Medical Communications Agencies:

Developing content for medical education and marketing.

Academic and Research Institutions

Assisting with grant writing, scientific publications, and research summaries.

Healthcare Providers

Creating patient education materials and internal communications.

Career Growth in Medical Writing

Medical writing offers significant potential for career growth and professional development. Here’s a typical career progression:

  • Entry-Level Medical Writer
    Start as a junior or associate medical writer to gain foundational experience in various types of medical writing.
  • Medical Writer
    Take on more complex projects and develop expertise in specific areas such as regulatory writing or scientific publications.
  • Senior Medical Writer
    Lead larger projects, mentor junior writers, and take on more strategic roles.
  • Principal Medical Writer or Writing Manager
    Oversee a team of writers, manage multiple projects, and ensure the quality and consistency of all written materials.
  • Director of Medical Writing
    Lead the medical writing department, set strategic goals, and collaborate with cross-functional teams to support organizational objectives.
  • Freelance Medical Writer
    Use your expertise and experience to offer writing services independently, providing flexibility and the opportunity to work with a variety of clients.

Why Pursue a Career in Medical Writing?

Intellectual Engagement

Stay at the forefront of medical and scientific advancements while engaging in intellectually stimulating work.

High Demand

The growing emphasis on evidence-based medicine and regulatory compliance drives the demand for skilled medical writers.

Diverse Opportunities

Work across various sectors and on different types of projects, ensuring a dynamic and varied career.

Professional Development

Continuously develop your skills and knowledge through ongoing learning and professional growth.

Impactful Work

Contribute to the advancement of medical knowledge and healthcare by ensuring accurate and effective communication of scientific information.

Start Your Journey Today!

Ready to embark on a fulfilling career in medical writing? Contact us to learn more about our training programs, certification courses, and how you can start your path to becoming a skilled medical writer.
Ring at : +91 7066457703
Join Us

Here Is The Most Frequently
Asked Questions

What inspired you to pursue a career in medical writing?

I have always had a passion for both science and writing. Medical writing offers the perfect blend of these interests by allowing me to engage deeply with scientific research while also communicating complex information clearly and accurately. Additionally, I am motivated by the opportunity to contribute to healthcare advancements by ensuring that important medical information is accessible and well-documented.

In my previous roles, I have written a variety of documents, including clinical study protocols, informed consent forms, clinical study reports, regulatory submission documents (such as INDs and NDAs), scientific manuscripts for publication, conference abstracts, posters, and educational materials for healthcare professionals and patients. This diverse experience has equipped me with the skills needed to handle different types of medical writing projects.

To ensure accuracy and clarity in my medical writing:

I thoroughly research and verify all information from reliable sources.
I use precise medical terminology and avoid ambiguity.
I follow established style guides and templates.
I review and edit my work multiple times and seek feedback from colleagues.
I maintain open communication with subject matter experts to clarify any uncertainties.
I stay updated with the latest developments in medical science and regulatory requirements.

I have extensive experience in regulatory writing, having prepared various submission documents such as Investigator’s Brochures, Clinical Study Reports (CSRs), Common Technical Document (CTD) modules, and Summary of Product Characteristics (SmPCs). I am familiar with guidelines from regulatory agencies like the FDA and EMA and have worked on both new drug applications (NDAs) and investigational new drug applications (INDs). My work involves ensuring that all documents are compliant with regulatory standards and thoroughly reviewed for accuracy and completeness.

 

To handle tight deadlines and multiple projects, I:

Prioritize tasks based on urgency and importance.
Create detailed project timelines and adhere to them.
Break down larger tasks into manageable steps.
Stay organized using project management tools.
Communicate effectively with team members to coordinate efforts.
Remain flexible and adaptable to adjust to changing priorities.
Ensure a healthy work-life balance to maintain productivity and focus.

Collaboration with cross-functional teams is crucial in medical writing. My approach includes:

Establishing clear communication channels from the outset.
Setting regular meetings to discuss progress, address issues, and align on objectives.
Respecting the expertise and input of all team members, including scientists, clinicians, and regulatory professionals.
Being open to feedback and making necessary adjustments to my work.
Ensuring all team members are informed of updates and changes in a timely manner.

One challenging project involved writing a clinical study report for a large-scale, multi-center trial with tight deadlines. The complexities included managing data from multiple sources and ensuring consistency and accuracy. To manage this, I:

Developed a detailed project plan with clear milestones.
Coordinated closely with data managers and statisticians to ensure data accuracy.
Held regular check-ins with the team to track progress and address any issues.
Worked extra hours when needed to meet deadlines without compromising quality.
Utilized feedback from peer reviews to refine the document.

I stay updated with the latest developments by:

Reading medical journals, industry publications, and regulatory updates.
Participating in webinars, conferences, and workshops related to medical writing and healthcare.
Being an active member of professional organizations such as the American Medical Writers Association (AMWA) or the European Medical Writers Association (EMWA).
Engaging in online forums and discussion groups with other medical writers and healthcare professionals.
Continuously pursuing relevant certifications and training opportunities.

I am proficient in various tools and software commonly used in medical writing, including:

Microsoft Office Suite (Word, Excel, PowerPoint) for document creation and data management.
Reference management software such as EndNote or Mendeley for organizing and citing sources.
Statistical software like SAS or SPSS for understanding and presenting data.
EDC systems like Medidata Rave and Oracle Clinical for managing clinical trial data.
Document management systems for tracking and version control.

To ensure compliance with regulatory guidelines:

I thoroughly familiarize myself with relevant regulatory documents and guidelines from agencies like the FDA, EMA, and ICH.
I use templates and checklists that align with these guidelines.
I regularly review updates and changes to regulatory requirements.
I work closely with regulatory affairs teams to ensure all submissions meet the necessary standards.
I attend training sessions and workshops focused on regulatory compliance.

I view feedback and revisions as opportunities for improvement. My approach includes:

Listening carefully to understand the feedback.
Asking clarifying questions if needed.
Incorporating the feedback thoughtfully and making necessary revisions.
Communicating any significant changes back to the reviewer to ensure alignment.
Using the feedback to improve my future work and avoid repeating mistakes.

In a previous role, I had to quickly learn about a new therapeutic area related to oncology. I approached this by:

Conducting an in-depth literature review to understand the basics and latest advancements.
Consulting with subject matter experts and attending relevant seminars.
Reviewing clinical trial data and previous regulatory submissions in that area.
Summarizing my findings and discussing them with colleagues to ensure comprehensive understanding.
Applying this knowledge to create accurate and insightful documents.

I ensure scientific accuracy by:

Thoroughly researching and verifying all information from credible sources.
Consulting with experts in the field to validate my understanding.
Using precise and consistent terminology.
Double-checking data and referencing all sources accurately.
Peer-reviewing my work and incorporating feedback from knowledgeable colleagues.

Common challenges include:

Complexity of Information: To manage this, I break down complex information into simpler, clear segments and consult with experts.
Tight Deadlines: I use effective time management and prioritize tasks to meet deadlines without compromising quality.
Maintaining Accuracy: I ensure thorough research, double-check facts, and seek peer reviews to maintain accuracy.
Regulatory Compliance: I stay updated with guidelines and collaborate with regulatory affairs teams to ensure compliance.

 

 I believe I am a good fit for this position because of my strong background in both science and writing, coupled with my attention to detail and ability to communicate complex information clearly. My experience in regulatory writing, familiarity with various therapeutic areas, and proficiency with relevant tools and software equip me to handle the responsibilities of this role effectively. Moreover, my dedication to continuous learning and professional development ensures that I stay current with industry standards and best practices.

Admission Enquiry

Let's chat